Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review

Bibliographic Details
Title: Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review
Authors: Jaime Lora-Tamayo, Mikel Mancheño-Losa, María Ángeles Meléndez-Carmona, Pilar Hernández-Jiménez, Natividad Benito, Oscar Murillo
Source: Antibiotics, Vol 13, Iss 4, p 293 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: biofilm, bone and joint infection, antimicrobial stewardship, arthroplasty infection, periprosthetic joint infection, implant-associated infection, Therapeutics. Pharmacology, RM1-950
More Details: Prosthetic joint infections are considered difficult to treat they needing aggressive surgery and long antimicrobial treatments. However, the exact duration of these therapies has been established empirically. In the last years, several studies have explored the possibility of reducing the length of treatment in this setting, with conflicting results. In this narrative review, we critically appraise the published evidence, considering the different surgical approaches (implant retention [DAIR] and one-step and two-step exchange procedures) separately. In patients managed with DAIR, usually treated for at least 12 weeks, a large, randomized trial failed to show that 6 weeks were non-inferior. However, another randomized clinical trial supports the use of 8 weeks, as long as the surgical conditions are favorable and antibiotics with good antibiofilm activity can be administered. In patients managed with a two-step exchange procedure, usually treated during 6 weeks, a randomized clinical trial showed the efficacy of a 4-week course of antimicrobials. Also, the use of local antibiotics may allow the use of even shorter treatments. Finally, in the case of one-step exchange procedures, there is a trend towards reducing the length of therapy, and the largest randomized clinical trial supports the use of 6 weeks of therapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2079-6382
Relation: https://www.mdpi.com/2079-6382/13/4/293; https://doaj.org/toc/2079-6382
DOI: 10.3390/antibiotics13040293
Access URL: https://doaj.org/article/6da8b9bebb5548b09b48562dd11eba98
Accession Number: edsdoj.6da8b9bebb5548b09b48562dd11eba98
Database: Directory of Open Access Journals
More Details
ISSN:20796382
DOI:10.3390/antibiotics13040293
Published in:Antibiotics
Language:English